Annual Non Current Assets
$11.76 M
+$1.55 M+15.16%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual long term assets is $11.76 million, with the most recent change of +$1.55 million (+15.16%) on December 31, 2021.
- During the last 3 years, PHAS annual non current assets has risen by +$11.36 million (+2853.77%).
Performance
PHAS Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Non Current Assets
$10.60 M
-$493.00 K-4.44%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly long term assets is $10.60 million, with the most recent change of -$493.00 thousand (-4.44%) on June 30, 2022.
- Over the past year, PHAS quarterly non current assets has dropped by -$1.53 million (-12.65%).
Performance
PHAS Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
PHAS Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.2% | -12.7% |
| 3 y3 years | +2853.8% | +317.2% |
| 5 y5 years | +3430.3% | - |
PHAS Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -9.8% | at low |
| 5 y | 5-year | at high | -68.8% | -16.3% | -65.4% |
| alltime | all time | at high | -98.0% | -16.3% | -96.9% |
PhaseBio Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $10.60 M(-4.4%) |
| Mar 2022 | - | $11.10 M(-5.6%) |
| Dec 2021 | $48.78 M(+21.5%) | $11.76 M(-5.8%) |
| Sep 2021 | - | $12.48 M(+2.9%) |
| Jun 2021 | - | $12.14 M(-4.2%) |
| Mar 2021 | - | $12.66 M(+24.1%) |
| Dec 2020 | $40.15 M | $10.21 M(+23.6%) |
| Sep 2020 | - | $8.26 M(+16.8%) |
| Jun 2020 | - | $7.07 M(+63.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $4.32 M(+17.6%) |
| Dec 2019 | $78.82 M(+25.9%) | $3.67 M(+29.5%) |
| Sep 2019 | - | $2.83 M(+11.5%) |
| Jun 2019 | - | $2.54 M(+10.0%) |
| Mar 2019 | - | $2.31 M(+480.7%) |
| Dec 2018 | $62.63 M(+354.9%) | $398.00 K(-84.2%) |
| Sep 2018 | - | $2.52 M(+168.9%) |
| Jun 2018 | - | $937.00 K(+181.4%) |
| Dec 2017 | $13.77 M(+254.4%) | $333.00 K |
| Dec 2016 | $3.88 M | - |
FAQ
- What is PhaseBio Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual non current assets year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly non current assets year-on-year change?
What is PhaseBio Pharmaceuticals annual long term assets?
The current annual non current assets of PHAS is $11.76 M
What is the all time high annual non current assets for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual long term assets is $11.76 M
What is PhaseBio Pharmaceuticals annual non current assets year-on-year change?
Over the past year, PHAS annual long term assets has changed by +$1.55 M (+15.16%)
What is PhaseBio Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of PHAS is $10.60 M
What is the all time high quarterly non current assets for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly long term assets is $12.66 M
What is PhaseBio Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, PHAS quarterly long term assets has changed by -$1.53 M (-12.65%)